ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 240 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2023. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,519,334 | -30.5% | 210,921 | -10.0% | 0.02% | -37.8% |
| Q2 2023 | $10,816,009 | -34.9% | 234,468 | -43.4% | 0.04% | -37.3% |
| Q1 2023 | $16,610,503 | +224245.0% | 414,227 | +159.2% | 0.06% | +118.5% |
| Q4 2022 | $7,404 | -99.9% | 159,819 | -15.5% | 0.03% | -10.0% |
| Q3 2022 | $7,830,000 | +1169.0% | 189,094 | +1727.0% | 0.03% | +1400.0% |
| Q2 2022 | $617,000 | -29.8% | 10,350 | -1.0% | 0.00% | -33.3% |
| Q4 2021 | $879,000 | +7.1% | 10,454 | +14.8% | 0.00% | 0.0% |
| Q3 2021 | $821,000 | -90.1% | 9,108 | -84.8% | 0.00% | -91.7% |
| Q4 2020 | $8,291,000 | – | 59,891 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 75,000 | $5,084,000 | 2.52% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 1,237,825 | $83,900,000 | 1.18% |
| CAPITAL INTERNATIONAL LTD /CA/ | 206,718 | $14,011,000 | 0.91% |
| Cormorant Asset Management, LP | 75,000 | $5,084,000 | 0.74% |
| Capital International Sarl | 107,450 | $7,283,000 | 0.63% |
| Rock Springs Capital Management LP | 159,750 | $10,828,000 | 0.62% |
| Opus Point Partners Management, LLC | 12,201 | $827,000 | 0.61% |
| Hood River Capital Management LLC | 109,629 | $7,431,000 | 0.56% |
| Aureus Asset Management, LLC | 50,740 | $2,927,000 | 0.51% |
| ROCKEFELLER FINANCIAL SERVICES INC | 374,663 | $25,395,000 | 0.51% |